; (B) information showing that the person seeking a technology certification order is an eligible person under subsection (b)(1); (C) information showing that the methods used in, and the facilities and controls used for, the development of eligible in vitro clinical tests covered by the scope of the technology certification conform to the applicable quality requirements of section 587J; (D) procedures for analytical validation, including all procedures for validation, ver­i­fi­ca­tion, and acceptance criteria, and an explanation as to how such procedures, when used, provide a reasonable assurance of analytical validity of all eligible in vitro clinical tests within the proposed scope of technology certification order; (E) information showing that the person has an established clinical program, including procedures for clinical validation, including all procedures for validation, verification, and acceptance criteria, and an explanation as to how such procedures, when used, provide a reasonable assurance of clinical validity of all eligible in vitro clinical tests within the proposed scope of technology certification order; (F) a notification under section 587I for each applicable in vitro clinical test that the developer plans to offer initially upon receiving a technology certification order and that would be introduced or delivered for introduction into interstate commerce upon the issuance of the technology certification order; (G) information concerning one or more representative in vitro clinical tests, including— (i) one of the tests within the scope of the technology certification application with the greatest analytical complexity at the time of the filing of the application under this section that would be introduced or delivered for introduction into interstate commerce upon the issuance of the technology certification order to serve as the representative test and validate and run within the developer’s stated scope, and a rationale for such selection